Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer [NA]

View source ↗

Summary

This document is an update on a neoadjuvant dietary intervention trial for intermediate-risk prostate cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | NA | Status: ACTIVE_NOT_RECRUITING